
Genecast
臻知医学
Genecast
Biotech/Healthcare
Zhenzhi Medical develops cancer immunotherapy technologies. It has established a target discovery platform covering tumor neoantigens and tumor-associated antigens, and has developed products including a cytokine release syndrome monitoring kit and an MPML immune score for assessing liver cancer…
Latest round: Series A (2024)
Source: ChinaBulls — chinabulls.com
Last updated 2024-10-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.